HSBC HOLDINGS PLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$359,377
+15.7%
17,427
+28.6%
0.00%
Q1 2023$310,644
+21.6%
13,553
+45.0%
0.00%
Q4 2022$255,550
+6.9%
9,349
+21.8%
0.00%
Q3 2022$239,0007,6740.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Crestline Management, LP 5,960,732$122,969,90114.32%
ARCH Venture Management, LLC 693,749$14,312,0429.30%
Flagship Pioneering Inc. 2,619,968$54,049,9403.92%
Casdin Capital, LLC 1,300,000$26,819,0002.97%
Yiheng Capital Management, L.P. 1,150,684$23,738,6111.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 154,000$3,172,4001.07%
SECTORAL ASSET MANAGEMENT INC 254,941$5,259,4331.02%
Temasek Holdings (Private) Ltd 6,895,992$142,264,3150.85%
Clarius Group, LLC 378,262$7,803,5450.74%
Artal Group S.A. 802,899$16,5640.71%
View complete list of DENALI THERAPEUTICS INC shareholders